1-4 of 4
Sonali Panchabhai, MBBS
Close
Sort by
Journal Articles

Immunomodulatory Drugs Inhibit H 2 O 2 Decomposition in Multiple Myeloma Cells and Its Mediated Cytotoxicity Is Determined By Cellular Antioxidative Capacity

Sinto Sebastian Chirackal, PhD, Yuan Xiao Zhu, PhD, Esteban Braggio, PhD, Chang-Xin Shi, PhD, Sonali Panchabhai, MBBS, Gregory Ahmann, BS, Scott A. Van Wier, BS, Marta Chesi, PhD, Leif Bergsagel, MD PhD, Keith Stewart, MD, Rafael Fonseca, MD
Journal: Blood
Blood (2015) 126 (23): 2475.
https://doi.org/10.1182/blood.V126.23.2475.2475
Published: 2015
Journal Articles

Ornithine Decarboxylase: Novel Prognostic Marker and Target for Multiple Myeloma Therapy

Sonali Panchabhai, MBBS, Ilana Miriam Schlam, MD, Sinto Sebastian Chirackal, PhD, Rafael Fonseca, MD
Journal: Blood
Blood (2015) 126 (23): 1824.
https://doi.org/10.1182/blood.V126.23.1824.1824
Published: 2015
Journal Articles

Intracellular Accumulation Of Light Chains Caused By Lenalidomide, and Mediated Via CRBN, Causes Major ER Stress and Is Implicated In The Synergistic Combination Of Imids and Proteasome Inhibitors

Sinto Sebastian, Ph.D., Yuan Xiao Zhu, PhD, Esteban Braggio, Ph.D., Sonali Panchabhai, MBBS, Chang-Xin Shi, Ph.D., Gregory Ahmann, BS, Leif Bergsagel, M.D., Rafael Fonseca, M.D.
Journal: Blood
Blood (2013) 122 (21): 4434.
https://doi.org/10.1182/blood.V122.21.4434.4434
Published: 2013
Journal Articles

Role Of Folate Receptor Targeted Therapy In Multiple Myeloma

Sonali Panchabhai, MBBS, Katalin Kelemen, MD, PhD, Sinto Sebastian Chirackal, PhD, BSc, MSc, Rafael Fonseca, M.D.
Journal: Blood
Blood (2013) 122 (21): 4436.
https://doi.org/10.1182/blood.V122.21.4436.4436
Published: 2013